GE HealthCare reported 2025 revenue of $20.63 billion and Q1 2026 revenue of $5.13 billion. The thesis turns on whether imaging, ultrasound, patient-care and pharmaceutical-diagnostics scale can keep converting into margin and cash while debt, hospital capital budgets and China exposure remain visible risks.
GE HealthCare: the med-tech spinoff has to turn installed base into cash
NASDAQGEHCCoverage BootstrapGE HealthCare Technologies Inc.
Thesis summary
GE HealthCare reported 2025 revenue of $20.63 billion and Q1 2026 revenue of $5.13 billion. The thesis turns on whether imaging, ultrasound, patient-care and pharmaceutical-diagnostics scale can keep converting into margin and cash while debt, hospital capital budgets and China exposure remain visible risks.
View article
Discuss the thesis
0 commentsCommenting requires active membershipBecome a member
Attack the thesis, not the person.Add evidence when challenging claims.No pump, spam, or low-effort comments.
No comments yet. Start the discussion with evidence, a question, or a bear case.